XML 165 R89.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Details) - USD ($)
1 Months Ended 12 Months Ended
Mar. 28, 2022
Mar. 02, 2022
Feb. 27, 2022
Jan. 10, 2022
Jan. 03, 2022
Feb. 28, 2022
Dec. 31, 2021
Jan. 14, 2022
Sep. 30, 2021
Dec. 31, 2020
Jul. 16, 2020
Dec. 31, 2019
Nasdaq Deficiency Notice [Abstract]                        
Stockholders' equity             $ (7,821,550)   $ 6,969,988 $ (2,640,693)   $ 4,617,244
March 2022 Registered Direct Offering [Abstract]                        
Warrants exercisable to purchase shares of common stock (in shares)                     137,746  
Series B Warrants [Member]                        
March 2022 Registered Direct Offering [Abstract]                        
Warrants exercisable to purchase shares of common stock (in shares)                     1,456,283  
2020 Plan [Member] | Maximum [Member]                        
Issuance of Stock Options [Abstract]                        
Common stock strike price for grants issued (in dollars per share)             $ 14.30          
Subsequent Event [Member]                        
Waiver Agreements with Certain Holders of Series B Convertible Preferred Stock [Abstract]                        
Preferred stock, par value (in dollars per share)               $ 0.0001        
Subsequent Event [Member] | Maximum [Member]                        
Nasdaq Deficiency Notice [Abstract]                        
Period to regain compliance       180 days                
Subsequent Event [Member] | Series B Warrants [Member]                        
Series B Most Favored Nations (MFN) Exchanges [Abstract]                        
Number of common stock, shares issued upon conversion convertible preferred stock (in shares) 104,735                      
Subsequent Event [Member] | Series C Warrants [Member] | Maximum [Member]                        
Series B Most Favored Nations (MFN) Exchanges [Abstract]                        
Number of common stock, shares issued upon conversion convertible preferred stock (in shares) 104,735                      
Subsequent Event [Member] | March 2022 Registered Direct Offering [Member]                        
March 2022 Registered Direct Offering [Abstract]                        
Shares reserved subject to issuance (in shares)     1,650,000                  
Non-offering period after closing date of March 2022 Registered Direct Offering     60 days                  
Subsequent Event [Member] | March 2022 Registered Direct Offering [Member] | March 2022 Pre-Funded Warrants [Member]                        
March 2022 Registered Direct Offering [Abstract]                        
Public offering price (in dollars per share)     $ 1.375                  
Subsequent Event [Member] | March 2022 Registered Direct Offering [Member] | March 2022 Pre-Funded Warrants [Member] | Maximum [Member]                        
March 2022 Registered Direct Offering [Abstract]                        
Warrants exercisable to purchase shares of common stock (in shares)     4,848,195                  
Subsequent Event [Member] | March 2022 Registered Direct Offering [Member] | Series C Warrants [Member]                        
March 2022 Registered Direct Offering [Abstract]                        
Public offering price (in dollars per share)     $ 1.385                  
Net proceeds from exercise of warrants   $ 8,100,000                    
Subsequent Event [Member] | March 2022 Registered Direct Offering [Member] | Series C Warrants [Member] | Maximum [Member]                        
March 2022 Registered Direct Offering [Abstract]                        
Warrants exercisable to purchase shares of common stock (in shares)     6,498,195                  
Subsequent Event [Member] | Waiver Agreements [Member]                        
Waiver Agreements with Certain Holders of Series B Convertible Preferred Stock [Abstract]                        
Preferred stock, par value (in dollars per share)           $ 0.0001            
Preferred stock, alternate redemption value           $ 7,700.00            
Value of preferred stock agreed to be waived with holders of preferred stock           2,880,000            
Value of preferred stock agreed to be waived with insiders           474,000            
Waiver fee paid           $ 0            
Series B Most Favored Nations (MFN) Exchanges [Abstract]                        
Conversion of stock, shares converted (in shares) 17.05                      
Conversion of stock amount converted $ 145,000                      
Subsequent Event [Member] | 2020 Plan [Member]                        
Issuance of Stock Options [Abstract]                        
Stock purchase period to employee         10 years              
Issuance of stock option to purchase common stock (in shares)         161,000              
Common stock strike price for grants issued (in dollars per share)         $ 1.45              
Stock options vesting period         3 years